Perminder S Sachdev1, Adith Mohan, Lauren Taylor, Dilip V Jeste. 1. From the Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales (Australia) (Drs. Sachdev and Mohan); Neuropsychiatric Institute,Prince of Wales Hospital, Sydney, Australia (Drs. Sachdev, Mohan, and Taylor); Department of Psychiatry and Neurosciences, University of California, San Diego (Dr. Jeste).
Abstract
LEARNING OBJECTIVES: After participating in this activity, learners should be better able to:• Assess the changes in DSM-5 relative to earlier versions.• Evaluate the implications of the DSM-5 for practicing geriatric psychiatrists. ABSTRACT: About every 20 years, the American Psychiatric Association revises its official classification of mental disorders. The fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) was published in 2013, prompting considerable commentary, debate, and criticism. This article briefly describes the process leading up to DSM-5 and the main changes from the previous version (DSM-IV) that would be of interest to a geriatric psychiatrist. The changes in the areas of schizophrenia, bipolar disorder, depressive disorders, and anxiety disorders have been many, but the majority of them are minor and unlikely to have major treatment implications. The classification of neurocognitive disorders, however, has seen a major revision and elaboration in comparison to DSM-IV; of special note is the introduction of "mild and major neurocognitive disorders," the latter equated with dementia. A common language has also been introduced for the criteria for the various etiological subtypes of neurocognitive disorders. All physicians treating patients with neurocognitive disorders should familiarize themselves with these criteria. Their use in research has the potential to harmonize the field.
LEARNING OBJECTIVES: After participating in this activity, learners should be better able to:• Assess the changes in DSM-5 relative to earlier versions.• Evaluate the implications of the DSM-5 for practicing geriatric psychiatrists. ABSTRACT: About every 20 years, the American Psychiatric Association revises its official classification of mental disorders. The fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) was published in 2013, prompting considerable commentary, debate, and criticism. This article briefly describes the process leading up to DSM-5 and the main changes from the previous version (DSM-IV) that would be of interest to a geriatric psychiatrist. The changes in the areas of schizophrenia, bipolar disorder, depressive disorders, and anxiety disorders have been many, but the majority of them are minor and unlikely to have major treatment implications. The classification of neurocognitive disorders, however, has seen a major revision and elaboration in comparison to DSM-IV; of special note is the introduction of "mild and major neurocognitive disorders," the latter equated with dementia. A common language has also been introduced for the criteria for the various etiological subtypes of neurocognitive disorders. All physicians treating patients with neurocognitive disorders should familiarize themselves with these criteria. Their use in research has the potential to harmonize the field.
Authors: G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman Journal: Neurology Date: 1993-02 Impact factor: 9.910
Authors: Darrel A Regier; William E Narrow; Diana E Clarke; Helena C Kraemer; S Janet Kuramoto; Emily A Kuhl; David J Kupfer Journal: Am J Psychiatry Date: 2013-01 Impact factor: 18.112
Authors: M Haution-Bitker; T Gilbert; A Vignoles; C Lecardonnel; S Watelet; E Blond; J Drai; M Bonnefoy Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Meghan Karuturi; Melisa L Wong; Tina Hsu; Gretchen G Kimmick; Stuart M Lichtman; Holly M Holmes; Sharon K Inouye; William Dale; Kah P Loh; Mary I Whitehead; Allison Magnuson; Arti Hurria; Michelle C Janelsins; Supriya Mohile Journal: J Geriatr Oncol Date: 2016-06-07 Impact factor: 3.599
Authors: Oskar Hansson; John Seibyl; Erik Stomrud; Henrik Zetterberg; John Q Trojanowski; Tobias Bittner; Valeria Lifke; Veronika Corradini; Udo Eichenlaub; Richard Batrla; Katharina Buck; Katharina Zink; Christina Rabe; Kaj Blennow; Leslie M Shaw Journal: Alzheimers Dement Date: 2018-03-01 Impact factor: 21.566
Authors: Marina Bruderer-Hofstetter; Mark A Dubbelman; André Meichtry; Florian Koehn; Thomas Münzer; Roos J Jutten; Philip Scheltens; Sietske A M Sikkes; Karin Niedermann Journal: Health Qual Life Outcomes Date: 2020-10-02 Impact factor: 3.186